ghk-cu face serum Copper Peptide Firming Achieve smooth Copper Peptides+ with GHK-CU Night

Beneath that surface similarity, however, they are genuinely different molecules: BPC-157 is a 15-amino-acid sequence isolated from a cytoprotective fraction of human gastric juice and characterized by Predrag Sikiric and the Zagreb group, while TB-500 is a 17-amino-acid synthetic fragment of the 43-residue actin-sequestering protein Thymosin Beta-4 (T4), originally isolated from calf thymus by Allan Goldstein and colleagues

After three months of twice-daily application, the Pure Copper peptide treatment group demonstrated superior outcomes in reducing lines and wrinkles, improving skin density, and increasing dermal thickness compared to both control groups

Pickart's research group went on to demonstrate that the Cu(II) coordination geometry an N3O distorted square-planar pyramid was the operative pharmacophore: free GHK without copper retains only a fraction of the wound-healing and gene-modulating activity of the chelate.[1][2] Research framework Within the matrix-remodeling and tissue-repair peptide research domain, GHK-Cu is most directly compared with BPC-157 for parallel cytoprotection and angiogenic signaling, with TB-500 for actin-cytoskeleton-mediated wound dynamics, and with Thymosin alpha-1 for companion immunoregulatory crosstalk

The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material